期刊文献+

黑曲霉发酵豆粕制备大豆异黄酮苷元的研究 被引量:6

Study on Solid Fermentation in Producing of Soybean Isoflavone Aglycon by Aspergillus niger
原文传递
导出
摘要 研究了以黑曲霉作为菌种对豆粕进行发酵生产大豆异黄酮苷元的方法,通过单因素试验和正交试验确定了发酵最佳培养基是豆粕质量分数25%,硫酸铵质量分数0.2%,固液比1:4(m:V),乳酸质量分数0.8%。发酵温度40℃,发酵时间18 h。在此条件下,黄豆苷元转化率81.77%,染料木黄酮转化率83.61%。 The experiment designed to study the method of isoflavone preparation by fermentation on soybean meal. According to the solo factor and the orthogonal test, it showed that the optimal substrate was the soybean residue 25%, ammonium sulfate 0.2%, solid-liquid ratio 1 : 4 (m: V) and 0.8% Lactic acid, the optimal fermentation conditions were the total time 18 h and the temperature 40 ℃. The transformation ratio of daidzein was 81.77%, and the transformation ratio of genistein was 83.61% under the conditions.
出处 《食品工业》 北大核心 2013年第5期26-29,共4页 The Food Industry
基金 国家高技术研究发展计划(863计划)(编号:2008AA10Z331)
关键词 黑曲霉 固态发酵法 大豆异黄酮苷元 高效液相色谱 Aspergillus niger solid fermentation soybean isoflavone aglycon HPLC
  • 相关文献

参考文献5

  • 1Wang H J, Murphy P A. Isoflavone composi -tion of American and Japanese soybeans in iowa: effects if variety crop year and location [J]. Journal of Agricultural and Food Chemistry, 1994, 42: 1674-1677.
  • 2Naim M, Gestetner B, Zikah S. Soybean Isoflav-ones. Characterization, Determination and Antifungal Activity [J]. J Agric Food Chem, 1974, 22: 806-810.
  • 3钱丽丽,张永忠,左锋.提高大豆异黄酮活性作用的研究进展[J].食品工业科技,2005,26(3):180-182. 被引量:11
  • 4XU X, HARRIS K S, Wang H J, et al. Bioavailabi-lity of soybean isoflavones depends upon gut microflora in women [J]. J Nutr, 1995, 125(9): 2307-2315.
  • 5井乐刚,张永忠.微生物发酵制备大豆异黄酮的研究进展[J].微生物学通报,2003,30(2):86-88. 被引量:27

二级参考文献17

  • 1姜蓉,李宝义,肖春玲,杨大军,吴剑波.新的异黄酮化合物K_3-D_3的分离和结构鉴定[J].中国抗生素杂志,1997,22(2):81-83. 被引量:3
  • 2Kudou S, Shimoyamada M, Imura T.A new isoflavone glycoside in soybean seeds (Glycine max Merrill),glycitein 7-O-β-D-(6"-O-acetyl)-glucopyranoside[J], Agric Biol Chem,1991,55:859-860.
  • 3Kudou S, Fleury Y ,Welti D. Malonyl isoflavone glycosides in soybean seeds (Glycine max Merrill) [J]. Agric Biol Chem, 1991,55:2227-2233.
  • 4Kurzer M S, Hormonal effects of soy in premenopausal women and men[J]. Nutr, 2002,132(3):5705-5735.
  • 5Lamartiniere C A, Cotroneo M S, Fritz W A, Wang J,Mentor-Marcel R, Elgavish A. Genistein chemoprevention:timing and mechanisms of action in murine mammary and prostate[J]. Nutr, 2002, 132(3):5525-5585.
  • 6Han K K, Soares J M, Haidar M A, Rodrigues de Lima G, Baracat E C. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms[J]. Obstet Gynecol, 2002,99(3): 389-394.
  • 7Kritz-Silverstein D ,Goodman-Gruen D L. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women[J]. Womens Health Gend Based Med, 2002,11(1):69-78.
  • 8Arena S, Rappa C, Del Frate E, Cenci S, Villani C. A natural alternative to menopausal hormone replacement therapy[J], Phytoestrogens Minerva Ginecol, 2002, 54(1): 53-57.
  • 9Patel R P, et al, Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging[J]. Free Radio Biol Med, 2001, 31(12) :1570-1581.
  • 10Paul, Stephen M, Hsu, Charles C. Hu, Qing-Fu. Noval preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflovone bioavailability [P].United States Patent, 2002, 0076455.

共引文献34

同被引文献141

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部